Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is CONMED Corporation (CNMD) A Good Stock To Buy?

There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Carl Icahn and George Soros think. Those hedge fund operators make billions of dollars each year by hiring the best and the brightest to do research on stocks, including small cap stocks that big brokerage houses simply don’t cover. Because of Carl Icahn and other elite funds’ exemplary historical records, we pay attention to their small cap picks. In this article, we use hedge fund filing data to analyze CONMED Corporation (NASDAQ:CNMD).

CONMED Corporation (NASDAQ:CNMD) shareholders have witnessed an increase in support from the world’s most elite money managers lately. CONMED Corporation (NASDAQ:CNMD) was in 19 hedge funds’ portfolios at the end of September. There were 17 hedge funds in our database with CONMED Corporation (NASDAQ:CNMD) holdings at the end of the previous quarter. At the end of this article, we will also compare CONMED Corporation (NASDAQ:CNMD) to other stocks, including Brink’S Company (NYSE:BCO), RealPage, Inc. (NASDAQ:RP), and Drew Industries, Inc. (NYSE:DW) to get a better sense of its popularity.

Follow Conmed Corp (NASDAQ:CNMD)
Trade (NASDAQ:CNMD) Now!

To most stock holders, hedge funds are viewed as underperforming, outdated investment vehicles of yesteryear. While there are more than 8000 funds in operation at the moment, our experts hone in on the aristocrats of this club, around 700 funds. These hedge fund managers command the lion’s share of the smart money’s total capital, and by keeping an eye on their unrivaled stock picks, Insider Monkey has determined several investment strategies that have historically outpaced the market. Insider Monkey’s small-cap hedge fund strategy surpassed the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Now, we’re going to take a look at the fresh action surrounding CONMED Corporation (NASDAQ:CNMD).

How have hedgies been trading CONMED Corporation (NASDAQ:CNMD)?

Heading into Q4, a total of 19 of the hedge funds tracked by Insider Monkey were long this stock, an increase of 12% from the second quarter. With the smart money’s capital changing hands, there exists a few key hedge fund managers who were boosting their holdings substantially (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Jacob Gottlieb’s Visium Asset Management has the largest position in CONMED Corporation (NASDAQ:CNMD), worth close to $111.7 million, accounting for 1.5% of its total 13F portfolio. Coming in second is Coppersmith Capital, led by Jerome Lande and Craig Rosenblum, holding a $77.9 million position; the fund has 72.6% of its 13F portfolio invested in the stock. Some other professional money managers that hold long positions include Ken Fisher’s Fisher Asset Management, Joe Huber’s Huber Capital Management, and Jonathon Jacobson’s Highfields Capital Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.